clinical-trials-doctor-blood-tube

The Clinical Trials and Statistics Unit at the ICR (ICR-CTSU)

Translating cutting-edge science into quality clinical trials that can transform cancer care

How we research at this centre

The ICR-CTSU is a Cancer Research UK-funded, internationally recognised methodologist led clinical trials unit, providing cancer-focussed clinical trial research expertise. We lead pioneering, efficient, high-quality, and impactful trials across the phases.

Our expertise ranges from experimental medicine early phase studies exploring biological efficacy to trials which may deliver widespread change to routine practice, underpinned by applied methodology to drive forward clinical trial innovation.

See our clinical trials

Our 2023-2027 research strategy 

Dispensing medicines for a clinical trial (Jan Chlebik/the ICR)

Our research

Find out about our clinical trials and trial methodology research.

Our research
clinical-trials-doctor-blood-tube

Working with us

We work with researchers worldwide to develop our research and maximise beneficial application of our data.

Working with us
A nurse and patient at the Royal Marsden Hospital

About us

Find out about our team's multidisciplinary approach and clinical trials expertise.

About us
The ICR logo on the exterior of the Brookes Lawley Building in Sutton

Contact ICR-CTSU

Get in touch with us for general enquiries and finding out more about our clinical trials.

Contact ICR-CTSU

News and discoveries at this centre

Maggie Cheang pictured smiling.
ICR researcher awarded prestigious lectureship for practice-changing breast cancer research

23/06/25

Dr Maggie Cheang, a breast cancer researcher at The Institute of Cancer Research, London, has been awarded the prestigious CL Oakley lectureship.
See full story
World's first trial to test multiple treatments for brain cancers

23/10/24

A pioneering research study which will allow brain cancer patients to access drugs that are precisely targeted to their disease and swap to different treatments if needed, has launched in the UK.
See full story
Nurse and patient on bed
New drug combination offers hope to women with rare treatment-resistant ovarian cancer

17/10/24

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ovarian cancer that rarely responds to chemotherapy or hormone therapy.
See full story
Cyberknife
Higher doses of radiotherapy cuts treatment time by 75% in localised prostate cancer patients, while maintaining high cure rates

16/10/24

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, according to researchers from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust.
See full story